NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Clinical trials for NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug trial halted early: what we know
Disease control TerminatedThis study tested a drug called VLS-101 in people with advanced solid tumors, including breast, lung, stomach, pancreatic, and ovarian cancers that had stopped responding to other treatments. The goal was to see if the drug could shrink tumors. However, the trial was stopped earl…
Matched conditions: NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Early cancer drug trial halted after just 3 patients
Disease control TerminatedThis was a very early (Phase 1) study testing a new drug called AMG 794 in adults with advanced lung, ovarian, or other solid tumors that had a specific marker (claudin 6). The main goal was to check safety and find the right dose. The study was stopped early after only 3 people …
Matched conditions: NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
Lung cancer combo trial halted early: what we know
Disease control TerminatedThis study tested a combination of three drugs (SHR-1210, famitinib, and chemotherapy) in people with advanced non-squamous non-small-cell lung cancer who had not received prior chemotherapy. The goal was to see if the combo could slow cancer growth better than a placebo plus che…
Matched conditions: NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Apr 26, 2026 19:39 UTC